CAS 203192-01-2

Formule : C32H40Br2N4

InChI : InChI=1S/C32H40N4.2BrH/c1-33(2)31-17-21-35(22-18-31)25-29-13-9-27(10-14-29)7-5-6-8-28-11-15-30(16-12-28)26-36-23-19-32(20-24-36)34(3)4;;/h9-24H,5-8,25-26H2,1-4H3;2*1H/q+2;;/p-2

Code InChI : YLHINOUDZGYMNO-UHFFFAOYSA-L

SMILES : CN(C)C1=CC=[N+](C=C1)CC2=CC=C(C=C2)CCCCC3=CC=C(C=C3)C[N+]4=CC=C(C=C4)N(C)C.[Br-].[Br-]

MN58b

CAS : 203192-01-2

MN58b

Formule : C₃₂H₄₀Br₂N₄

Degré de pureté : 97%

Masse moléculaire : 640.49

Ref: 54-BUP08618

MN58b

CAS : 203192-01-2

MN58b is a selective inhibitor of choline kinase α (CHKα).

Formule : C₃₂H₄₀Br₂N₄

Degré de pureté : 97.23%

Couleur et forme : Solid

Masse moléculaire : 640.495

Ref: TM-T12085

MN58b

CAS : 203192-01-2

1,1'-((Butane-1,4-diylbis(4,1-phenylene))bis(methylene))bis(4-(dimethylamino)pyridin-1-ium) bromide

Formule : C₃₂H₄₀Br₂N₄

Degré de pureté : 98%

Masse moléculaire : 640.49

Ref: IN-DG01176276

MN58b

CAS : 203192-01-2

MN58b is a novel chemotherapeutic drug that is clinically relevant to the treatment of autoimmune diseases. MN58b has been shown to be toxic to primary cells, with potential for chemotherapy. MN58b may be used in the treatment of cancer and other autoimmune diseases by inhibiting the production of inflammatory cytokines such as TNF-α and IL-6. The mechanism of action is not well understood, but it has been shown to inhibit toll-like receptor signaling pathways. This agent also exhibits antimicrobial activity against Gram-positive bacteria and fungi.

Formule : C₃₂H₄₀Br₂N₄

Degré de pureté : Min. 95%

Masse moléculaire : 640.5 g/mol

Ref: 3D-DIA19201

(5-Chloropyridin-2-yl)(thiomorpholino)methanone

CAS : 203192-01-2

Formule : C₃₂H₄₀Br₂N₄

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 640.4948

Ref: IN-DA01JUI8